Review



c lipofermata  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    MedChemExpress c lipofermata
    ( A and B ) FATP2 and loading control GAPDH mRNA expression was determined in human and mouse pancreatic tissue and α cell lines by RT-PCR (as described in Methods). Data are representative of 3 experiments per condition. ( C ) Mouse αTC1-6 cells were preincubated with <t>lipofermata</t> (1 hour, 37°C, 0–50 μM) in triplicate. BODIPY-labeled fatty acid uptake velocity was then determined, as described in Methods. Results show the mean ± SEM of 4 experiments.
    C Lipofermata, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c lipofermata/product/MedChemExpress
    Average 93 stars, based on 10 article reviews
    c lipofermata - by Bioz Stars, 2026-03
    93/100 stars

    Images

    1) Product Images from "Fatty acid transport protein 2 inhibition enhances glucose tolerance through α cell–mediated GLP-1 secretion"

    Article Title: Fatty acid transport protein 2 inhibition enhances glucose tolerance through α cell–mediated GLP-1 secretion

    Journal: The Journal of Clinical Investigation

    doi: 10.1172/JCI192011

    ( A and B ) FATP2 and loading control GAPDH mRNA expression was determined in human and mouse pancreatic tissue and α cell lines by RT-PCR (as described in Methods). Data are representative of 3 experiments per condition. ( C ) Mouse αTC1-6 cells were preincubated with lipofermata (1 hour, 37°C, 0–50 μM) in triplicate. BODIPY-labeled fatty acid uptake velocity was then determined, as described in Methods. Results show the mean ± SEM of 4 experiments.
    Figure Legend Snippet: ( A and B ) FATP2 and loading control GAPDH mRNA expression was determined in human and mouse pancreatic tissue and α cell lines by RT-PCR (as described in Methods). Data are representative of 3 experiments per condition. ( C ) Mouse αTC1-6 cells were preincubated with lipofermata (1 hour, 37°C, 0–50 μM) in triplicate. BODIPY-labeled fatty acid uptake velocity was then determined, as described in Methods. Results show the mean ± SEM of 4 experiments.

    Techniques Used: Control, Expressing, Reverse Transcription Polymerase Chain Reaction, Labeling

    ( A ) Pancreatic GLP-1 + α cell mass was determined as described in Methods in db/db and FATP2-KO db/db mice. * P < 0.01 compared with the db/db group by t test. ( B ) Human islets were preincubated with or without lipofermata (LF) and then tested for glucose-stimulated GLP-1 secretion as described in Methods. * P < 0.01 compared with all other groups by ANOVA. ( C ) αTC1-6 cells were preincubated with or without lipofermata or palmitate (Palm) as indicated. Glucose-stimulated GLP-1 secretion was then measured as described in Methods. Each symbol in the scatter bars in B and C represents 1 sample that was assayed in duplicate ( n = 3–6 samples per condition). * P < 0.05 compared lipofermata plus palmitate by ANOVA. ( D ) αTC1-6 cells coincubated in 5 mM or 25 mM glucose with or without 400 μM palmitate with or without 50 μM lipofermata for 16 hours were analyzed for Pcsk1 and Pcsk2 mRNA expression by qPCR. The results are expressed as the ratio relative to the 5 mM glucose-only condition. * P < 0.05 compared with other groups by ANOVA. ( E ) Glucose-stimulated insulin secretion was measured in human islets, which were preincubated with or without lipofermata and then exposed to exendin[9-39] (Ex) or palmitate, as described in Methods. Each symbol in the scatter bars represents 1 sample that was assayed in duplicate ( n = 3 samples per condition). * P < 0.01 compared with 16.8 mM glucose plus the lipofermata group by ANOVA. Data represent the mean ± SEM.
    Figure Legend Snippet: ( A ) Pancreatic GLP-1 + α cell mass was determined as described in Methods in db/db and FATP2-KO db/db mice. * P < 0.01 compared with the db/db group by t test. ( B ) Human islets were preincubated with or without lipofermata (LF) and then tested for glucose-stimulated GLP-1 secretion as described in Methods. * P < 0.01 compared with all other groups by ANOVA. ( C ) αTC1-6 cells were preincubated with or without lipofermata or palmitate (Palm) as indicated. Glucose-stimulated GLP-1 secretion was then measured as described in Methods. Each symbol in the scatter bars in B and C represents 1 sample that was assayed in duplicate ( n = 3–6 samples per condition). * P < 0.05 compared lipofermata plus palmitate by ANOVA. ( D ) αTC1-6 cells coincubated in 5 mM or 25 mM glucose with or without 400 μM palmitate with or without 50 μM lipofermata for 16 hours were analyzed for Pcsk1 and Pcsk2 mRNA expression by qPCR. The results are expressed as the ratio relative to the 5 mM glucose-only condition. * P < 0.05 compared with other groups by ANOVA. ( E ) Glucose-stimulated insulin secretion was measured in human islets, which were preincubated with or without lipofermata and then exposed to exendin[9-39] (Ex) or palmitate, as described in Methods. Each symbol in the scatter bars represents 1 sample that was assayed in duplicate ( n = 3 samples per condition). * P < 0.01 compared with 16.8 mM glucose plus the lipofermata group by ANOVA. Data represent the mean ± SEM.

    Techniques Used: Expressing



    Similar Products

    c lipofermata  (MedChemExpress)
    93
    MedChemExpress c lipofermata
    ( A and B ) FATP2 and loading control GAPDH mRNA expression was determined in human and mouse pancreatic tissue and α cell lines by RT-PCR (as described in Methods). Data are representative of 3 experiments per condition. ( C ) Mouse αTC1-6 cells were preincubated with <t>lipofermata</t> (1 hour, 37°C, 0–50 μM) in triplicate. BODIPY-labeled fatty acid uptake velocity was then determined, as described in Methods. Results show the mean ± SEM of 4 experiments.
    C Lipofermata, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c lipofermata/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    c lipofermata - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    ( A and B ) FATP2 and loading control GAPDH mRNA expression was determined in human and mouse pancreatic tissue and α cell lines by RT-PCR (as described in Methods). Data are representative of 3 experiments per condition. ( C ) Mouse αTC1-6 cells were preincubated with lipofermata (1 hour, 37°C, 0–50 μM) in triplicate. BODIPY-labeled fatty acid uptake velocity was then determined, as described in Methods. Results show the mean ± SEM of 4 experiments.

    Journal: The Journal of Clinical Investigation

    Article Title: Fatty acid transport protein 2 inhibition enhances glucose tolerance through α cell–mediated GLP-1 secretion

    doi: 10.1172/JCI192011

    Figure Lengend Snippet: ( A and B ) FATP2 and loading control GAPDH mRNA expression was determined in human and mouse pancreatic tissue and α cell lines by RT-PCR (as described in Methods). Data are representative of 3 experiments per condition. ( C ) Mouse αTC1-6 cells were preincubated with lipofermata (1 hour, 37°C, 0–50 μM) in triplicate. BODIPY-labeled fatty acid uptake velocity was then determined, as described in Methods. Results show the mean ± SEM of 4 experiments.

    Article Snippet: Wells were washed with serum-free, phenol-free media for 2 hours at 37° C. Lipofermata (5-bromo-5′-phenylspiro[3 H -1,3,4-thiadiazole-2,3′-indoline]-2-1) (MedChemExpress) was robotically incubated for the final hour.

    Techniques: Control, Expressing, Reverse Transcription Polymerase Chain Reaction, Labeling

    ( A ) Pancreatic GLP-1 + α cell mass was determined as described in Methods in db/db and FATP2-KO db/db mice. * P < 0.01 compared with the db/db group by t test. ( B ) Human islets were preincubated with or without lipofermata (LF) and then tested for glucose-stimulated GLP-1 secretion as described in Methods. * P < 0.01 compared with all other groups by ANOVA. ( C ) αTC1-6 cells were preincubated with or without lipofermata or palmitate (Palm) as indicated. Glucose-stimulated GLP-1 secretion was then measured as described in Methods. Each symbol in the scatter bars in B and C represents 1 sample that was assayed in duplicate ( n = 3–6 samples per condition). * P < 0.05 compared lipofermata plus palmitate by ANOVA. ( D ) αTC1-6 cells coincubated in 5 mM or 25 mM glucose with or without 400 μM palmitate with or without 50 μM lipofermata for 16 hours were analyzed for Pcsk1 and Pcsk2 mRNA expression by qPCR. The results are expressed as the ratio relative to the 5 mM glucose-only condition. * P < 0.05 compared with other groups by ANOVA. ( E ) Glucose-stimulated insulin secretion was measured in human islets, which were preincubated with or without lipofermata and then exposed to exendin[9-39] (Ex) or palmitate, as described in Methods. Each symbol in the scatter bars represents 1 sample that was assayed in duplicate ( n = 3 samples per condition). * P < 0.01 compared with 16.8 mM glucose plus the lipofermata group by ANOVA. Data represent the mean ± SEM.

    Journal: The Journal of Clinical Investigation

    Article Title: Fatty acid transport protein 2 inhibition enhances glucose tolerance through α cell–mediated GLP-1 secretion

    doi: 10.1172/JCI192011

    Figure Lengend Snippet: ( A ) Pancreatic GLP-1 + α cell mass was determined as described in Methods in db/db and FATP2-KO db/db mice. * P < 0.01 compared with the db/db group by t test. ( B ) Human islets were preincubated with or without lipofermata (LF) and then tested for glucose-stimulated GLP-1 secretion as described in Methods. * P < 0.01 compared with all other groups by ANOVA. ( C ) αTC1-6 cells were preincubated with or without lipofermata or palmitate (Palm) as indicated. Glucose-stimulated GLP-1 secretion was then measured as described in Methods. Each symbol in the scatter bars in B and C represents 1 sample that was assayed in duplicate ( n = 3–6 samples per condition). * P < 0.05 compared lipofermata plus palmitate by ANOVA. ( D ) αTC1-6 cells coincubated in 5 mM or 25 mM glucose with or without 400 μM palmitate with or without 50 μM lipofermata for 16 hours were analyzed for Pcsk1 and Pcsk2 mRNA expression by qPCR. The results are expressed as the ratio relative to the 5 mM glucose-only condition. * P < 0.05 compared with other groups by ANOVA. ( E ) Glucose-stimulated insulin secretion was measured in human islets, which were preincubated with or without lipofermata and then exposed to exendin[9-39] (Ex) or palmitate, as described in Methods. Each symbol in the scatter bars represents 1 sample that was assayed in duplicate ( n = 3 samples per condition). * P < 0.01 compared with 16.8 mM glucose plus the lipofermata group by ANOVA. Data represent the mean ± SEM.

    Article Snippet: Wells were washed with serum-free, phenol-free media for 2 hours at 37° C. Lipofermata (5-bromo-5′-phenylspiro[3 H -1,3,4-thiadiazole-2,3′-indoline]-2-1) (MedChemExpress) was robotically incubated for the final hour.

    Techniques: Expressing